Jiangxi Synergy Pharmaceutical Co.,Ltd.’s Net Profit Rose 5.6% in First Three Quarters of 2023

Jiangxi Synergy Pharmaceutical Co.,Ltd. (江西同和药业股份有限公司) (300636.SZ) reported a net profit of 78.7 million yuan in the first three quarters of 2023, up 5.6% year-on-year.

Meanwhile, the company posted 559.7 million yuan in revenue, up 5.9% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 30.3%.